JPRN-UMIN000014558招募中未知
Phase2 study of Nab-Paclitaxel in patients with unresectable or advanced squamous cell lung cancer - Phase2 study of Nab-Paclitaxel in patients with unresectable or advanced squamous cell lung cancer
Tottori University Faculty of Medicine0 个研究点目标入组 27 人开始时间: 2014年7月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient with need of procedure for pleural effusion 2) History of hypersensitivity against albumin preparation 3) Patient with need of drainage procedure for cardiac effusion 4) Patient with symptomatic brain metastasis 5) Patient with severe complications. 6) Patients with interstitial pneumonia or pulmonary fibrosis diagnosed by chest X-ray 7) Female Patient in or having a chance or planning of pregnancy or breast feeding, 8) Male patient in planning to impregnate 9) Patient with active multiple cancers. 10) Patients with history of drug hypersensitivity 11) Patinets with histoly of hypersensitivity against Txeane agents include paclitaxel and docetaxel 12) Case which was judged as impossible to perform by physician in charge
研究者
相似试验
已完成
2 期
Phase 2 study of Nab-Paclitaxel for patients with previously treated EGFR wild-type non-small-cell lung cancer.on-small-cell lung cancerJPRN-UMIN000018233Shimane university hospital45
已完成
不适用
Phase II study of nab-paclitaxel in patients with previously treated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012114Osaka City General Hospital30
已完成
不适用
Phase II Study of nab-paclitaxel in Treated Patients with Advanced Non-Small Cell Lung CancerTreated patients with advanced non-small cell lung cancerJPRN-UMIN000015841Tohoku Medical and Pharmaceutical University30
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22
已完成
2 期
Phase II clinical study of nab-paclitaxel for patients with recurrent advanced non-small cell lung cancer.advanced non-small cell lung cancerJPRN-UMIN000016932The Japan-Multinational Trial Organization (JMTO)81